0001104659-23-039363.txt : 20230330
0001104659-23-039363.hdr.sgml : 20230330
20230330201602
ACCESSION NUMBER: 0001104659-23-039363
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230328
FILED AS OF DATE: 20230330
DATE AS OF CHANGE: 20230330
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SILBER ALLAN C
CENTRAL INDEX KEY: 0001009161
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39373
FILM NUMBER: 23782487
MAIL ADDRESS:
STREET 1: C/O COUNSEL CORPORATION
STREET 2: 700 - 1 TORONTO ST.
CITY: TORONTO
STATE: A6
ZIP: M5C 2V6
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: POINT Biopharma Global Inc.
CENTRAL INDEX KEY: 0001811764
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850800493
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
BUSINESS PHONE: (317) 543-9957
MAIL ADDRESS:
STREET 1: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
FORMER COMPANY:
FORMER CONFORMED NAME: Therapeutics Acquisition Corp.
DATE OF NAME CHANGE: 20200511
4
1
tm2311087-6_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-03-28
0
0001811764
POINT Biopharma Global Inc.
PNT
0001009161
SILBER ALLAN C
4850 WEST 78TH STREET
INDIANAPOLIS
IN
46268
1
1
1
0
Executive Chairman
0
Stock Option (Right to Buy)
6.78
2023-03-28
4
A
0
537322
0.00
A
2029-03-28
Common Stock
537322
537322
D
The option vests 25% on the first anniversary of the date of grant with the remaining 75% vesting in three equal annual installments thereafter.
/s/ William L. Demers, by Power of Attorney for Allan C. Silber
2023-03-30